SCHEMBL7775365

SCHEMBL7775365

CC(C)Oc1ccccc1N1CCN(C(N)Cc2nc3ccc(F)cc3s2)CC1

nearest known ligand 0.41

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ADRA1A P35348 8/20 0.41
ADRA1D P25100 7/20 0.41
ADRA1B P35368 6/20 0.41
DRD4 P21917 2/20 0.40
DRD2 P14416 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL7775343 0.99 ADRA1A (0.41) ADRA1AADRA1DADRA1BDRD4DRD2
SCHEMBL7856190 0.90 POLB (0.45) DRD2
SCHEMBL7773451 0.89 MAPT (0.49) DRD4DRD2
Bromide SCHEMBL7848009 0.88 MAPT (0.49) DRD4DRD2
SCHEMBL27571997 0.87 NPC1 (0.39) DRD4DRD2
SCHEMBL7775363 0.85 HTR2A (0.38) DRD4DRD2
Bromide SCHEMBL7857246 0.84 HTR2A (0.38) DRD4DRD2
Fumaric Acid SCHEMBL7855789 0.83 MAPT (0.47) DRD2
SCHEMBL27565727 0.82 NPC1 (0.46) DRD4DRD2
Bromide SCHEMBL27545758 0.81 NPC1 (0.46) DRD4DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1117663-A2 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 2001-07-25 EP claimed
WO-2000018767-A9 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORP (US) 2001-04-19 WO claimed
WO-2000018767-A2 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 2000-04-06 WO claimed
WO-2000018767-A9 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORP (US) 2001-04-19 WO disclosed